The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global healthcare additive manufacturing market reached a value of US$ XX Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Additive manufacturing (AM) is utilized to manufacture prototypes with 3D computer-aided design (CAD). In the healthcare sector, AM is used for manufacturing diagnostic equipment and implants. It minimizes the production costs and reduces the number of in-theatre parts. It is a commercially viable alternative that facilitates complex geometries and mass customization of parts than traditional manufacturing methods such as milling, forging, and fabrication. Nowadays, healthcare AM finds application in orthopedics, implantology, and dentistry. It also provides personalization for medical practitioners and surgeons as it creates organic shapes specific to each user.
The global healthcare AM market is primarily driven by the growing demand for customized medical implants. Healthcare AM helps achieve complex and customized medical components and parts such as tissues, organs, cranial implants, and prosthetics. Furthermore, the rise in the number of surgeries due to the growing prevalence of chronic disorders has necessitated the use of 3D printing technology. This allows surgeons to be more precise, reduce risks and operate faster, thereby providing a positive outlook for the market. Moreover, several innovations and technological advancements, such as the introduction of speed prototyping and testing materials and designs that are cost-effective in nature, are further contributing to the market growth. Various regulatory bodies, such as the United States Food and Drug Administration (US FDA), have been actively involved in understanding the technology to provide a broader pathway and aid efficient access to safe and effective innovations enabled by AM.
IMARC Group provides an analysis of the key trends in each sub-segment of the global healthcare additive manufacturing market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on technology, material and application.
Breakup by Technology:
Breakup by Material:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3D Systems Inc., 3T Additive Manufacturing Ltd., Allevi Inc., EnvisionTEC GmbH, EOS GmbH, Fathom, General Electric, Materialise, Nanoscribe GmbH & Co. KG, RegenHU and Stratasys Ltd.
|Base Year of the Analysis||2020|
|Segment Coverage||Technology, Material, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||3D Systems Inc., 3T Additive Manufacturing Ltd., Allevi Inc., EnvisionTEC GmbH, EOS GmbH, Fathom, General Electric, Materialise, Nanoscribe GmbH & Co. KG, RegenHU and Stratasys Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at